Evolución de la malaria en la región Loreto

  1. Juan Celis S.
  2. Roxana Montenegro
  3. Alfredo Castillo
  4. Elizabeth Che
  5. Aníbal Muñóz
Revue:
Anales de la Facultad de Medicina

ISSN: 1025-5583,  1609-9419

Année de publication: 2003

Volumen: 64

Número: 4

Pages: 261-266

Type: Article

DIALNET GOOGLE SCHOLAR lock_openAccès ouvert editor

D'autres publications dans: Anales de la Facultad de Medicina

Résumé

OBJECTIVES: To describe the evolution of malaria at the Loreto Region, comparing vivaxwith falciparum malaria, its evolution in comparison with the rest of Peru and the changes inmedicinal policy. MATERIAL AND METHODS: Observational and descriptive study. TheMinistry of Health General Epidemiology Office was the source of information. RESULTS:Both vivax and falciparum malaria incidence at the Loreto Region has increased since 2000,following a reduction of 40%. An increase of 24% was reported in 2001 with respect to 2000and 52% in 2002 with respect to 2001. As a percentage of all cases in Peru, Loreto accountedfor 29%, 31%, 44%, 47% and 57%, respectively, in the years 1998 through 2002. Loreto hasbeen at high risk since 1995. In 2003 at the 46rd Epidemiology Week (09th – 15th November)Loreto (IPA 45) and San Martin (IPA 10) were placed at high risk; 60,4% of all cases comefrom Loreto. CONCLUSIONS: Loreto Region malaria incidence has been increasing in the last3 years. Peruvian cases of malaria in the last few years have been centered at the LoretoRegion

Références bibliographiques

  • Sachs J, Malaney P. The economic and social burden ofmalaria. Nature 2002; 415: 680–5
  • Guerin PJ, Olliaro P, Nosten F, Druilhe P, LaxminarayanR, Binka F, et al. Malaria: Current status of control,diagnosis, treatment, and a proposed agenda for researchand development. Lancet Infect Dis[serial online] 2002; 2:564–73.
  • Mandell D, Bennett JE. Principles and Practice ofInfectious Diseases. En: Donald JK. Plasmodium Species(Malaria), 5th Ed. New York: Churchill Livingstone;2000:1351-65.
  • Quimper M. Malaria en la Región Loreto: Investigaciónpara el Proyecto Integrado de Malaria en la Región Loreto.CARE-Perú, Julio 1998.
  • Magill AJ, García C, Solari L, Ylquimiche L, VásquezM, Carey C, et al. Therapeutic efficacy of pyrimethamine-sulfadoxine in Peruvian Amazon. American Society ofTropical Medicine and Hygiene Meeting, Abstract N0 329;Washington D.C. Nov 28 – Dec 2, 1999.
  • Nosten F, van Vugt M, Price R, Luxemburger C, ThwayKL, Brockman A, et al. Effects of artesunate-mefloquinecombination on incidence of Plasmodium falciparum mala-ria and mefloquine resistance in western Thailand: aprospective study. Lancet 2000; 356: 297–302.
  • Wongsrichanalai Ch, Pickard AL, Wernsdorfer WH,Meshnick SR. Epidemiology of drug-resistant malaria.Lancet Infect Dis[serial online]2002; 2: 209–18.
  • Calderón G, Fernández R, Valle J. Especies de la faunaanofelina, su distribución y algunas consideraciones sobresu abundancia e infectividad en el Perú. Rev Per Epidemiol1995; 8 (1): 5-23.
La source de données: Dialnet